Research Article
Clinical Situations of Bacteriology and Prognosis in Patients with Urosepsis
Table 4
Drug resistance of two Gram-positive bacteria of Enterococcus spp.
| ā | Enterococcus faecium | Enterococcus faecalis | ā | n | Drug resistance rate% | n | Drug resistance rate% |
| Ampicillin | 5 | 100.0% | - | - | Penicillin G | 5 | 100.0% | 6 | 100.0% | Benzylpenicillin | - | - | 5 | 83.3% | Vancomycin | 1 | 20.0% | 0 | 0.0% | Teicoplanin | 1 | 20.0% | 0 | 0.0% | Linezolid | 0 | 0.0% | 0 | 0.0% | Ciprofloxacin | 5 | 100.0% | 2 | 33.3% | Levofloxacin | 5 | 100.0% | 1 | 16.7% | Moxifloxacin | 5 | 100.0% | 0 | 0.0% | Clindamycin/chloramphenicol | 2 | 40.0% | 5 | 83.3% | Erythromycin | 3 | 60.0% | 6 | 100.0% | Gentamicin | - | - | 2 | 33.3% | High-level gentamicin | 4 | 80.0% | 0 | 0.0% | High-level streptomycin | 1 | 20.0% | 0 | 0.0% | Tetracycline | 3 | 60.0% | 1 | 16.7% | Tigecycline | 0 | 0.0% | - | - |
|
|